Log in
Enquire now
‌

LSP BioVentures

A Cambridge-based venture capital firm that invests in companies within the life science sector

OverviewStructured DataIssuesContributors

Contents

lsp.nl...ex.php
Is a
Venture capital firm
Venture capital firm
Investor
Investor
Company
Company
Organization
Organization

Company attributes

Industry
Pharmaceutical industry
Pharmaceutical industry
Location
Cambridge, Massachusetts
Cambridge, Massachusetts
Founded Date
2006

Venture Capital Firm attributes

Invested in
NousCom
NousCom
0
‌
arGEN-X
‌
Activaero
Imcyse
Imcyse
0
‌
Aelin Therapeutics
0
Evommune
Evommune
0
Muna Therapeutics
Muna Therapeutics
0
Lumeon
Lumeon
0

Other attributes

Company Operating Status
Active

LSP BioVentures is a venture capital firm in Cambridge that prefers to invest in companies in the life science sector. Founded 2006 in Cambridge, Massachusetts, the firm invests in early stage ventures and late stage ventures. The notable investment portfolio of LSP BioVentures includes Imcyse, Lumeon, Aelin Therapeutics, Nouscom, Eloxx, Rainier Therapeutics, Immunic, Luxendo, Sequana Medical, and arGEN-X. As of January 2020, LSP BioVentures has made 14 investments and seven exits.

Timeline

No Timeline data yet.

Funding Rounds

Products

Acquisitions

SBIR/STTR Awards

Associated Investment Funds

Accelerator Batches

Patents

Funding Rounds Participated In

Further Resources

Title
Author
Link
Type
Date
No Further Resources data yet.

References

Find more companies like LSP BioVentures

Use the Golden Query Tool to find similar companies in the same industry, location, or by any other field in the Knowledge Graph.
Open Query Tool
Access by API
Golden Query Tool
Golden logo

Company

  • Home
  • Press & Media
  • Blog
  • Careers
  • WE'RE HIRING

Products

  • Knowledge Graph
  • Query Tool
  • Data Requests
  • Knowledge Storage
  • API
  • Pricing
  • Enterprise
  • ChatGPT Plugin

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us
By using this site, you agree to our Terms of Service.